Trial Profile
Hydroxychloroquine as Add On Therapy Patients of Type 2 Diabetes Mellitus Uncontrolled on Sulfonylurea and Metformin Combination Comparison with Gliptins-real world Efficacy assessment in India (HOPE INDIA study) - HOPE-INDIA
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jul 2019
Price :
$35
*
At a glance
- Drugs Hydroxychloroquine (Primary) ; Sitagliptin (Primary) ; Teneligliptin (Primary) ; Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms HOPE-INDIA
- 13 Nov 2018 New trial record